| Product Code: ETC11877161 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
Suriname import shipments of enteric disease testing and therapeutics saw significant growth in 2024, with top exporting countries including the United States, Curacao, Netherlands, Germany, and China. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, while the compound annual growth rate (CAGR) from 2020 to 2024 was negative at -3.31%. However, there was a notable uptick in growth from 2023 to 2024, with a growth rate of 21.98%. This suggests a potential shift in market dynamics and increasing demand for enteric disease-related products in Suriname.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Enteric Disease Testing and Therapeutic Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Enteric Disease Testing and Therapeutic Market - Industry Life Cycle |
3.4 Suriname Enteric Disease Testing and Therapeutic Market - Porter's Five Forces |
3.5 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By Testing Type, 2021 & 2031F |
3.6 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.9 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Suriname Enteric Disease Testing and Therapeutic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Suriname Enteric Disease Testing and Therapeutic Market Trends |
6 Suriname Enteric Disease Testing and Therapeutic Market, By Types |
6.1 Suriname Enteric Disease Testing and Therapeutic Market, By Testing Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Testing Type, 2021 - 2031F |
6.1.3 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Molecular Testing, 2021 - 2031F |
6.1.4 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Stool Culture, 2021 - 2031F |
6.1.5 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Serological Testing, 2021 - 2031F |
6.1.6 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Rapid Testing Kits, 2021 - 2031F |
6.2 Suriname Enteric Disease Testing and Therapeutic Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Gastroenteritis, 2021 - 2031F |
6.2.3 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Cholera, 2021 - 2031F |
6.2.4 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Salmonella Infection, 2021 - 2031F |
6.2.5 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume, By E. Coli Infection, 2021 - 2031F |
6.3 Suriname Enteric Disease Testing and Therapeutic Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Research Labs, 2021 - 2031F |
6.3.4 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.3.5 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4 Suriname Enteric Disease Testing and Therapeutic Market, By Treatment Type |
6.4.1 Overview and Analysis |
6.4.2 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Antiviral Therapy, 2021 - 2031F |
6.4.3 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Antibiotic Therapy, 2021 - 2031F |
6.4.4 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Probiotic Therapy, 2021 - 2031F |
6.4.5 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Vaccine Therapy, 2021 - 2031F |
6.5 Suriname Enteric Disease Testing and Therapeutic Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.5.3 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Specialty Pharmacies, 2021 - 2031F |
6.5.4 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Online Retail, 2021 - 2031F |
6.5.5 Suriname Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Direct Sales, 2021 - 2031F |
7 Suriname Enteric Disease Testing and Therapeutic Market Import-Export Trade Statistics |
7.1 Suriname Enteric Disease Testing and Therapeutic Market Export to Major Countries |
7.2 Suriname Enteric Disease Testing and Therapeutic Market Imports from Major Countries |
8 Suriname Enteric Disease Testing and Therapeutic Market Key Performance Indicators |
9 Suriname Enteric Disease Testing and Therapeutic Market - Opportunity Assessment |
9.1 Suriname Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By Testing Type, 2021 & 2031F |
9.2 Suriname Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 Suriname Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Suriname Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.5 Suriname Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Suriname Enteric Disease Testing and Therapeutic Market - Competitive Landscape |
10.1 Suriname Enteric Disease Testing and Therapeutic Market Revenue Share, By Companies, 2024 |
10.2 Suriname Enteric Disease Testing and Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here